Advertisement

Topics

Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers

2018-04-18 09:14:12 | BioPortfolio

Published on BioPortfolio: 2018-04-18T09:14:12-0400

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic Gonadotrophin in Women Undergoing In Vitro Fertilisation

The purpose of the study is to evaluate the clinical equivalence and the general tolerability of two different subcutaneous hCG preparations (hCG-IBSA, IBSA vs Ovitrelle, Serono) when admi...

hCG Supplementation in Frozen-Thawed Embryo Transfer Cycle

The implantation rate after frozen-thawed embryo transfer cycles depends mostly on the receptivity of the endometrium and the embryo quality.The effects of human chorionic gonadotropins (h...

PubMed Articles [0 Results]

None

Medical and Biotech [MESH] Definitions

None available.

More From BioPortfolio on "Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial